Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings

Shares (Q2 2026)
17,826
Value
$663.3K
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of CLDX by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,826$663.3K<0.1%−35,034−66.3%ReducedHolders
Q1 202652,860$1.68M<0.1%−83,464−61.2%ReducedHolders
Q4 2025136,324$3.70M<0.1%−121,008−47.0%ReducedHolders
Q3 2025257,332$6.66M<0.1%−388,325−60.1%ReducedHolders
Q2 2025645,657$13.1M<0.1%+239,496+59.0%AddedHolders
Q1 2025406,161$7.37M<0.1%−112,179−21.6%ReducedHolders
Q4 2024518,340$13.1M<0.1%−306,777−37.2%ReducedHolders
Q3 2024825,117$28.0M<0.1%−20,443−2.4%ReducedHolders
Q2 2024845,560$31.3M<0.1%+272,389+47.5%AddedHolders
Q1 2024573,171$24.1M<0.1%+549,425+2,313.8%AddedHolders
Q4 202323,746$941.8K<0.1%−13,038−35.4%ReducedHolders
Q3 202336,784$1.01M<0.1%+7,700+26.5%AddedHolders
Q2 202329,084$986.8K<0.1%+2,534+9.5%AddedHolders
Q1 202326,550$955.3K<0.1%−3,954−13.0%ReducedHolders
Q4 202230,504$1.36M<0.1%−78,161−71.9%ReducedHolders
Q3 2022108,665$3.06M<0.1%−33,055−23.3%ReducedHolders
Q2 2022141,720$3.82M<0.1%+19,548+16.0%AddedHolders
Q1 2022122,172$4.16M<0.1%−52,613−30.1%ReducedHolders
Q4 2021174,785$6.75M<0.1%+60,861+53.4%AddedHolders
Q3 2021113,924$6.15M<0.1%+83,625+276.0%AddedHolders
Q2 202130,299$1.01M<0.1%+30,299NewHolders